Can I get it?
Not for this use. Bimatoprost has no EU authorisation for it, so it cannot be prescribed or dispensed here for that purpose.
Why buying it online is risky
Bimatoprost · Genoa
Bimatoprost in Genoa: what you should know.
NOT AVAILABLE IN THE EUBimatoprost has no EU marketing authorisation for this use.
We don't prescribe it today, but our doctors can review your case and propose an equivalent hair growth treatment with EU approval and clinical evidence.
€15/month (billed €45 every 90 days)Full refund if a review is not approved
IN PLAIN TERMS
What Bimatoprost is, and how to get treatment
Bimatoprost has three separate stories and it is easy to mix them up. As eye drops it is authorised across the EU under the brand Lumigan to lower pressure inside the eye in glaucoma and ocular hypertension. As a liquid brushed onto the upper eyelid it is approved in some markets outside the EU, sold as Latisse in the United States, to treat inadequate eyelashes. Using it on the scalp for pattern hair loss is a third, different thing: it is off-label and still investigational, it has no marketing authorisation for that use anywhere, and Hi-Doctor does not prescribe it for hair loss.
Bimatoprost has no EU marketing authorisation for this use. It may be an approved medicine for something else, or approved in another country — but not something a doctor here can prescribe for this.
What can I take instead?
Minoxidil is approved in the EU, has published peer-reviewed trial results, and can be prescribed today if a doctor decides it suits you.
Read about MinoxidilWhat do the studies show?
Every trial behind Bimatoprost is listed below with its registry number, how many people took part, and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Can I get Bimatoprost in Genoa?
Not through Hi-Doctor. Hi-Doctor does not prescribe Bimatoprost. People in Genoa, Italy, can request an online consultation for Hair growth with a licensed EU doctor, who may recommend an available option when clinically appropriate. If approved, the EU prescription arrives as a PDF for a pharmacist in Italy, who dispenses the locally marketed equivalent with the prescribed active ingredient.
Availability
Hi-Doctor does not prescribe Bimatoprost. The links below show options in Hair growth that our doctors can assess.
- Country
- Italy
- Language of service
- Spanish and English
- Prescription turnaround
- In less than 4 hours on average, only if the doctor approves
- Honoured locally
- PDF honoured locally for the prescribed active ingredient
How the EU prescription works where you are: In Italy, show the approved prescription PDF to a pharmacist. They honour it under EU cross-border rules and dispense the locally marketed equivalent with the prescribed active ingredient.
TREATMENT OPTIONS
Available hair-growth treatments
A licensed doctor decides case by case. We never prescribe without evaluation.
Rx · tablets
Prescription only
Oral finasteride
A 5-alpha-reductase inhibitor taken daily. A doctor may prescribe it after reviewing your history and ruling out contraindications.
Daily tablets
€15/month
Rx · tablets
Prescription only
Oral minoxidil
Low-dose oral minoxidil, used off-label by some dermatologists. Requires close medical supervision for potential cardiovascular effects.
Daily tablets
€15/month
OTC · lotion
Prescription only
Topical minoxidil
Solution or foam applied directly to the scalp. Can be combined with other actives in a compounded formulation.
Lotion or foam
€15/month
Rx · tablets
Prescription only
Dutasteride 0.5mg
A more potent 5-alpha-reductase inhibitor. Reserved for specific cases, always under medical evaluation.
Tablets
€15/month
Rx · compounded
Prescription only
Personalised compounded formulation
An individualised preparation that can combine finasteride, minoxidil, tretinoin, or other actives, compounded by pharmacies after a medical prescription.
Individual preparation
€15/month
You pay for any medication separately at the pharmacy you choose. Hi-Doctor does not sell medications.
WHAT IT COSTS
One plan, reviewed by a doctor.
Hair growth
ONGOING PLAN
€15/month
Billed €45 every 90 days · cancel anytime
For ongoing treatment and doctor-reviewed renewals.
Lowest monthly price we offer
Start consultation
Full refund if a review is not approved
WHAT'S INCLUDED
- First consultation included
- Renewals reviewed by your doctor
- Ongoing care with your doctor
- Cancel anytime
Full refund if a review is not approved
If a review is not approved, we refund that period's €45 fee and cancel the plan.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
VERIFIED EVIDENCE
Bimatoprost: evidence and regulatory guide.
WHAT IT IS
How it works
Bimatoprost is a man-made version of a natural body substance called a prostaglandin; in the eye it helps fluid drain away so pressure inside the eye falls, and on the eyelid it is thought to lengthen the growing phase of the eyelash hair cycle.
DEVELOPMENT STAGE
Not marketed in the EU
Trial register1 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (Allergan, Phase 2)NCT01904721 | Men with mild to moderate androgenetic alopecia, bimatoprost solution or vehicle applied to the scalp twice daily for 6 months | 244 | Read out | — |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Regulatory document
ClinicalTrials.gov posted results, NCT01904721 (Allergan, Phase 2, 244 participants). Stage 2, mean change from baseline in target area hair count at Month 6.| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| Bimatoprost Solution 1, scalp, twice daily | +12.7 terminal hairs/cm2 (SD 26.4) | 26 |
| Bimatoprost Solution 2, scalp, twice daily | +9.3 terminal hairs/cm2 (SD 23.1) | 26 |
| Vehicle (no active medicine), scalp, twice daily | +5.8 terminal hairs/cm2 (SD 21.0) | 26 |
These are registry-posted results from a single six-month phase 2 study; the public record labels the concentrations only as Solution 1 and Solution 2, and bimatoprost holds no marketing authorisation for scalp hair loss in the EU or anywhere else.
Sources
Last reviewed 2026-07-27
- EMA EPAR - Lumigan (bimatoprost eye drops), EMEA/H/C/000391, authorised in the EU for glaucoma and ocular hypertension
- EMA - Lumigan product information (SmPC)
- FDA label - LATISSE (bimatoprost ophthalmic solution) 0.03%, indicated for hypotrichosis of the eyelashes (US only)
- ClinicalTrials.gov - NCT01904721, bimatoprost in men with androgenetic alopecia (results)
- ClinicalTrials.gov · NCT01904721
NAMED SAFETY SIGNALS
What has been reported with Bimatoprost.
Red eyes
In the eye-drop formulation authorised in the EU, conjunctival hyperaemia is very common: about 29% of patients in a 12-month phase III study of Lumigan 0.1 mg/ml, mostly trace to mild.
Changes around the eye
The Lumigan product information lists prostaglandin analogue periorbitopathy as very common, and eyelid redness, eyelid itching and eyelash growth as common.
Permanent change in eye colour
Iris hyperpigmentation is listed as an uncommon adverse reaction in the Lumigan product information; the US Latisse label carries a specific warning about increased brown iris pigmentation.
Skin darkening and unwanted hair
Skin hyperpigmentation and hypertrichosis are listed as common in the Lumigan product information; the US Latisse label warns about hair growth outside the intended treatment area.
UNAPPROVED PRODUCTS ONLINE
Why buying Bimatoprost online is not a shortcut.
No doctor in the EU can prescribe it for this use — including ours. It may be authorised in another country, or for a different condition.
Check the EU common logo
A legitimate online pharmacy in the EU must display the common logo linked to its national register. The logo is a verification check; it cannot make an unapproved medicine legal.
How the EU common logo worksFREQUENTLY ASKED QUESTIONS
Questions about Bimatoprost.
OTHER HAIR GROWTH TREATMENTS